Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Sep;18(9):1456-1458.
doi: 10.1513/AnnalsATS.202107-762ED.

Too Much or Too Little Empiric Treatment for Pseudomonas aeruginosa in Community-acquired Pneumonia?

Antoni Torres  1 , Michael S Niederman  2
Affiliations
Editorial

Too Much or Too Little Empiric Treatment for Pseudomonas aeruginosa in Community-acquired Pneumonia?

Antoni Torres et al. Ann Am Thorac Soc. 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
An algorithm to guide when to use empiric anti-Pseudomonal therapy for community-acquired pneumonia. This algorithm combines data from scoring systems (–11) along with Gram staining of a lower respiratory tract sample and historical data about prior antibiotic use and prior respiratory tract colonization by Pseudomonas aeruginosa. CAP = community-acquired pneumonia.
None
See this image and copyright information in PMC

Comment on

References

    1. Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG, et al. Pneumonia. Nat Rev Dis Primers. 2021;7:25. - PubMed
    1. Cillóniz C, Gabarrús A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, et al. Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa. Chest. 2016;150:415–425. - PubMed
    1. Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, et al. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia. Respirology. 2015;20:660–666. - PubMed
    1. Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, et al. GLIMP. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018;52:1701190. - PubMed
    1. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45–e67. - PMC - PubMed